Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus

JAMA Dermatol. 2020 Jul 1;156(7):813-814. doi: 10.1001/jamadermatol.2020.1074.

Abstract

This cohort study uses data from a medical record review of a dermatogynecology practice to describe the association between reduced recurrence of vulvar squamous cell carcinoma and use of topical corticosteroids in the treatment of vulvar lichen sclerosus.

Publication types

  • Letter

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use*
  • Betamethasone / analogs & derivatives
  • Betamethasone / therapeutic use
  • Carcinoma in Situ / prevention & control*
  • Carcinoma, Squamous Cell / prevention & control*
  • Clobetasol / therapeutic use
  • Desonide / therapeutic use
  • Female
  • Humans
  • Hydrocortisone / therapeutic use
  • Methylprednisolone / analogs & derivatives
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Neoplasm Recurrence, Local / prevention & control*
  • Vulvar Lichen Sclerosus / drug therapy*
  • Vulvar Neoplasms / prevention & control*

Substances

  • Anti-Inflammatory Agents
  • betamethasone-17,21-dipropionate
  • Betamethasone
  • Clobetasol
  • methylprednisolone aceponate
  • Desonide
  • Hydrocortisone
  • Methylprednisolone